$MLTX
MoonLake Immunotherapeutics
Nasdaq · Healthcare · Pharmaceutical Preparations · Zug, Switzerland
MLTX chart
What traders are saying about $MLTX
Latest postsMoonLake Immunotherapeutics news
- Is MoonLake Immunotherapeutics (MLTX) Cheap On Earnings Losses And Sonelokimab Milestones?
Yahoo Finance ·
- MoonLake Immunotherapeutics (MLTX) Reports Wider Net Loss, Is It Still Below Fair Value?
Simply Wall St ·
- MoonLake Immunotherapeutics Stock In Focus After Quarterly Loss Update
Yahoo Finance ·
- MoonLake Shares In Focus After Wider Third Quarter Loss at MoonLake Immunotherapeutics (MLTX)
Simply Wall St ·
- Weekly Recap: IZAR-1 meets Week 16 endpoints and Q3 loss exceeds estimates
TradingView ·
- Swiss biopharma firm taps Miami for U.S. headquarters
The Business Journals ·
- Molson Coors downgraded, SiTime upgraded: Wall Street's top analyst calls
Yahoo Finance ·
- MoonLake Immunotherapeutics Stock Price Prediction: Today, Tomorrow, Next Week (MLTX)
Traders Union ·
- How Far Does USD 498.5 Million Stretch for MoonLake Immunotherapeutics (NASDAQ:MLTX) Post-Filing?
kalkine.ca ·
- Leerink Partners Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $30
Moomoo ·
- How Is MoonLake Immunotherapeutics (NASDAQ:MLTX) Advancing Sonelokimab Toward U.S. Approval and Beyond?
Kalkine ·
- Wedbush Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $34
Moomoo ·
MoonLake Immunotherapeutics key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$227.3M | -$118.9M | -$36.0M | -$50.0M |
| Diluted EPS | $-3.53 | $-1.89 | $-0.73 | $-1.70 |
| Total assets (year end) | $424.4M | $477.9M | $526.5M | $76.8M |
| Cash and equivalents (year end) | $334.5M | $180.4M | $451.2M | $39.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-Q10-Q
- 8-K8-K
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-K8-K
About MoonLake Immunotherapeutics
- Ticker
- MLTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Zug, Switzerland
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1821586
- Former names
- Helix Acquisition Corp
Frequently asked questions
What exchange is MoonLake Immunotherapeutics listed on?
MoonLake Immunotherapeutics trades on the Nasdaq under the ticker symbol MLTX.
What industry is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is MoonLake Immunotherapeutics headquartered?
MoonLake Immunotherapeutics's business address on file with the SEC is in Zug, Switzerland.
When does MoonLake Immunotherapeutics's fiscal year end?
MoonLake Immunotherapeutics's fiscal year ends on December 31.